Open Journal Systems

Diagnostic Value of Tumor Markers CA153 and CA125 in Breast Cancer

Yuxia Sun (The First People's Hospital of Zhengzhou City,Zhengzhou,China)


Objective. To investigate the diagnostic value of CA153 and CA125 combined examination in breast cancer patients. Methods: selecting the first people's hospital of Zhengzhou city in April 2018 to April 2019 accepts 60 cases of breast cancer patients as observation group, at the same time to choose healthy check-up women 60 cases as control group, two groups of all to carry out the tumor markers CA153, CA125 joint inspection, summarizes the tumor markers CA153, CA125 joint inspection in the sensitivity of diagnosis of breast cancer. RESULTS: There were statistically significant differences in the positive rates of tumor marker CA153 and CA125 combined detection between the two groups (P < 0.05), and the higher the stage of breast adenocarcinoma, the higher the levels of tumor marker CA153 and CA125. Conclusion: Combined examination of tumor markers CA153 and CA125 can reduce the incidence of clinical misdiagnosis of breast cancer.


Tumor markers; CA153; CA125; Breast cancer

Full Text:



Wang Qunshuan, Li Xiaohua. Clinical significance of nuclear magnetic resonance combined with serum tumor markers and cytogenes in the diagnosis of breast cancer [J]. Shaanxi Journal of Medical Sciences, 2019,48 (10):1295-1297.

XIong J. To explore the value of combined detection of tumor markers (CA153, CA199, CA125, CEA) in the diagnosis of breast cancer, ovarian cancer and colorectal cancer [J]. Chinese Community Physician, 2017,33 (1):93-94.

Yang Jiewen, Luo Ling. Clinical significance of serum tumor markers CA153, CEA, CA125, CYFRA211 in early diagnosis of breast cancer [J]. Chinese Journal of Applied Medicine, 2014,9 (27):1-2.

Piaping, Tian Liu. Analysis of the value of CA153 and CA125 in the diagnosis of breast adenocarcinoma [J]. Journal of Applied Cancer, 2017,32 (8): 1351-1353.

Wang Ying, Li Zhangai, Huang Hua. Diagnostic value of multiple tumor markers in screening and diagnosis of female breast adenocarcinoma [J]. Chinese Journal of Maternal and Child Health, 2019, 34(6):1274-1276.



  • There are currently no refbacks.

Copyright (c) 2020 Yuxia Cui

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.